Table 3 Patient characteristics and IBL undergoing open gastrectomy with D2 lymph-node dissection for gastric cancer
High IBL (n = 42) (%) | Low IBL (n = 58) (%) | p value | |
|---|---|---|---|
Age (years) | 68.5 ± 8.1 | 64.2 ± 10.6 | 0.0318 |
Gender | 0.4271 | ||
Male | 32 (76.2) | 40 (70.0) | |
Female | 10 (23.8) | 18 (30.0) | |
BMI (kg/m2) | 0.0100 | ||
<25 | 28 (66.7) | 51 (87.9) | |
≥25 | 14 (33.3) | 7 (12.1) | |
VFA (cm2) | 0.0041 | ||
<100 | 21 (50.0) | 45 (77.6) | |
≥100 | 21 (50.0) | 13 (22.4) | |
SFA (cm2) | 123.1 ± 53.6 | 110.5 ± 54.2 | 0.2530 |
Tumor location | 0.0020 | ||
U | 10 (23.8) | 2 (3.4) | |
M/L | 32 (76.2) | 56 (96.6) | |
Macroscopic type | 0.8455 | ||
Superficial | 14 (33.3) | 17 (29.3) | |
Well-defined | 15 (35.7) | 20 (34.5) | |
Ill-defined | 13 (31.0) | 21 (36.2) | |
Tumor size (mm) | 60.8 ± 33.2 | 51.0 ± 26.3 | 0.1016 |
Histological type | 0.3589 | ||
Differentiated | 20 (47.6) | 33 (56.9) | |
Undifferentiated | 22 (52.4) | 25 (43.1) | |
Depth of invasion | 0.1134 | ||
T1 | 12 (28.6) | 21 (36.2) | |
T2 | 20 (47.6) | 16 (27.6) | |
T3 | 10 (23.8) | 21 (36.2) | |
Lymph-node metastasis | 0.1364 | ||
N0 | 15 (35.7) | 29 (50.0) | |
N1 | 16 (38.1) | 20 (34.4) | |
N2 | 8 (19.0) | 9 (15.5) | |
N3 | 3 (7.1) | 0 (0) | |
Stage | 0.3351 | ||
IA | 8 (19.0) | 14 (24.1) | |
IB | 7 (16.7) | 15 (25.9) | |
II | 11 (26.2) | 11 (19.0) | |
IIIA | 6 (14.3) | 11 (19.0) | |
IIIB | 4 (9.5) | 5 (8.6) | |
IV | 6 (9.5) | 2 (3.4) | |
Preoperative complications | 0.8447 | ||
Absence | 24 (57.1) | 32 (55.2) | |
Presence | 18 (42.9) | 18 (31.0) | |
LigaSure Atlas | 0.1050 | ||
Used | 17 (40.5) | 33 (56.9) | |
Not used | 25 (59.5) | 25 (43.1) | |
Operative procedure | 0.0015 | ||
Distal gastrectomy | 24 (57.1) | 43 (74.1) | |
Total gastrectomy | 18 (42.9) | 15 (25.9) | |
Splenectomy | <0.0001 | ||
Absence | 24 (57.1) | 52 (89.7) | |
Presence | 18 (42.9) | 6 (10.3) |